FDA-Approved Alzheimer's Drugs Show Promise in Slowing Cognitive Decline
New review examines breakthrough amyloid-targeting immunotherapies that represent the first disease-modifying treatments for Alzheimer's.
1,007 articles in this topic
New review examines breakthrough amyloid-targeting immunotherapies that represent the first disease-modifying treatments for Alzheimer's.
Dr. Dacher Keltner reveals the neuroscience of awe and practical tools to cultivate this powerful emotion for better health and connection.
Scientists developed mitoDREADD-Gs, a novel tool that restores cognitive function by enhancing mitochondrial activity in mouse models of dementia.
New review reveals promising tau-targeting therapies showing cognitive benefits and slowed brain pathology in Alzheimer's trials.
Two breakthrough approvals target Hunter syndrome brain complications and cerebral folate deficiency for the first time.
UC Berkeley psychologist reveals the neuroscience of awe and practical tools to cultivate this powerful emotion daily.
New precision medicine approach combines genetic risk factors with environmental exposures to predict and prevent dementia.
Research reveals concerning lung complications in MS patients treated with ocrelizumab, raising important safety questions.
Major study finds remote neurologist consultations superior to bedside visits for stroke care quality and guideline adherence.
Research explores how having a meaningful place of belonging supports psychological resilience following traumatic events.
UC Berkeley researchers discovered brain circuits linking deep sleep to growth hormone release, revealing how sleep builds muscle and burns fat.
New research reveals that consuming caffeine at night, but not during the day, significantly increases impulsive behavior in females.